External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

Equity Bottom-Up

Integra Lifesciences Holdings / Equity Bottom-Up

Key points (machine generated)<ul><li>Integra enjoys a high level of trust in the quality and reliability of its products, particularly in the neurosurgical equipment and wound healing grafts segments.</li><li>The acquisition of Codman in 2017 resulted in a significant expansion of Integra's neurosurgery sub-segment.</li><li>Surgeons prefer Integra's brands due to their superior performance and the trust they have in the company's products. The tissue segment uses a variety of raw materials, including animal sources and synthetic materials.</li></ul>This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Key points (machine generated)Integra enjoys a high level of trust in the quality and reliability of its products, particularly in the neurosurgical equipment and wound healing grafts segments.The acquisition of Codman in 2017 resulted in a significant expansion of Integra's neurosurgery sub-segment.Surgeons prefer Integra's brands due to their superior performance and the trust they have in the company's products. The tissue segment uses a variety of raw materials, including animal sources and synthetic materials.This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Integra Lifesciences Holdngs (IART) - Friday, Oct 27, 2023

United States

Integra LifeSciences Holdings Corp develops, manufactures, and markets medical devices, implants, and biomaterials. The Company's products are primarily used in the treatment of burns and skin defects, spinal and cranial disorders, orthopedics, and other surgical applications.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Integra Lifesciences Holdings (IART US)

Integra Lifesciences Holdngs (IART) - Friday, Oct 27, 2023

Integra enjoys a high level of trust in the quality and reliability of its products, particularly in the neurosurgical equipment and wound healing...

Value Investors Club

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)